Abstract
Vital to patient safety is the accurate assessment and minimization of risk for human immunodeficiency virus (HIV), Hepatitis C (HCV), and Hepatitis B (HBV) virus transmission by deceased donor organ and tissue transplantation. The pathogens are tested by serological kits based on enzyme-linked immunosorbent assay (ELISA), chemiluminescence (CLIA) and eletrochemiluminescence (ECLIA) immunoassays. Organ transplantation is a highly successful life-saving treatment in Brazil, but the Brazilian Health Surveillance Agency currently mandates that all deceased organ donors are screened for HIV, HCV and HBV following living donor policies. In this review, six ELISA (Wama®, Bio-Rad®, Biomerieux®, DiaSorin®, Acon Biotech® and Biokit®), three CLIA (Abbott®, Siemens®, Diasorin®) and one ECLIA (Roche®) were utilized for evaluating the effectiveness of those serological tests for deceased donors in Brazil according to manufacturer’s guidelines. NAT for HIV, HCV and HBV can assist with detection of pre-seroconversion for those infections, and only Cobas® TaqScreen MPX® test, the Tigris System® Procleix Ultrio Assay® and the Bio-Manguinhos® HIV/HCV/HBV NAT are commercially available. Between all the tests, only the manufacturer Abbott® and Cobas® TaqScreen MPX® test are currently validated for cadaver samples.
Similar content being viewed by others
Abbreviations
- Anti-HBc:
-
Antibody to hepatitis B virus core antigen
- Anti-HCV:
-
Hepatitis C virus antibody
- Anti-HIV 1/2:
-
Human immunodeficiency 1 and 2 virus antibody
- ANVISA:
-
Brazilian Health Surveillance Agency
- CLIA:
-
Chemiluminescent assay
- ECLIA:
-
Eletrochemiluminescent assay
- ELISA:
-
Enzyme linked immuno sorbent assay
- HBsAg:
-
Hepatitis B virus surface antigen
- NAT:
-
Nucleic acid test
- PCR:
-
Polymerase chain reaction
References
Abbott® (2013a) ARCHITECT® Anti-HBc II
Abbott® (2013b) ARCHITECT® HBsAg Qualitative
Abbott® (2014a) ARCHITECT® Anti-HCV
Abbott® (2014b) ARCHITECT® HIV Ag/Ab Combo
ADVIA Centaur®, ADVIA Centaur® XP, ADVIA Centaur® XPT HBc Total (HBcT) (2014) Siemens Healthcare Diagnostics Inc
ADVIA Centaur® and ADVIA Centaur® XP HBsAg (HBs) (2010) Siemens Healthcare Diagnostics Inc
ADVIA Centaur®, ADVIA Centaur® XP HIV 1/O/2 Enhanced (EHIV) (2012) Siemens Healthcare Diagnostics Inc
Anti-HBsAg II: Antibodies to hepatitis B surface antigen (2015) Roche Diagnostics®
Anti-HBc: Antibodies to hepatitis B core antigen (anti-HBc) (2015) Roche Diagnostics®
Anti-HCV: Antibody to hepatitis C virus (anti-HCV) (2015) Roche Diagnostics®
Appierto V, Callari M, Cavadini E, Morelli D, Daidone MG, Tiberio P (2014) A lipemia-independent NanoDrop(R)-based score to identify hemolysis in plasma and serum samples. Bioanalysis 6:1225–1226. doi:10.4155/bio.13.344
Associação Brasileira de Transplante de Órgãos (2014) Dimensionamento dos Transplantes no Brasil e em cada estado (2007-2014), 2014 [Internet]. Registro Brasileiro de Transplantes, São Paulo
Associação Brasileira de Transplante de Órgãos (2015) Dimensionamento dos Transplantes no Brasil e em cada estado (2008-2015), 2015 [Internet]. Registro Brasileiro de Transplantes, São Paulo
Associação Brasileira de Transplante de Órgãos (2016) Dados Númericos da doação de órgãos e transplantes realizados por estado e instituição no período: Janeiro / Março - 2016, 2016 [Internet]. Registro Brasileiro de Transplantes, São Paulo
Bioelisa® anti-HBc (2012) BioKit®
Bioelisa® HBsAg 3.0 (2012) BioKit®
Bioelisa® HCV 4.0 (2012) BioKit®
Bioelisa® HIV 1/2 3.0 (2012) BioKit®
Bio-Manguinhos®FioCruz (2015) Kit NAT HIV/HBV/HCV®
Bio-Rad® (2006) MONOLISA® HCV Ag-Ab ULTRA
Brasil (2008) RDC 67, de 30 de setembro de 2008. Dispõe sobre o Regulamento Técnico para o Funcionamento de Bancos de Tecidos Oculares de origem humana
Brasil (2009) Portaria MS Nº 2.600, de 21 de outubro de 2009 Aprova o Regulamento Técnico do Sistema Nacional de Transplantes
Brasil (2014) Dispõe sobre as Boas Práticas no Ciclo de Sangue vol RDC 304
Calmarza P, Cordero J (2011) Lipemia interferences in routine clinical biochemical tests. Biochem Med 21:160–166
Chen D, Kaplan LA (2006) Performance of a new-generation chemiluminescent assay for hepatitis B surface antigen. Clin Chem 52:1592–1598. doi:10.1373/clinchem.2005.064063
Chigurupati P, Murthy KS (2015a) Automated nucleic acid amplification testing in blood banks: an additional layer of blood safety. Asian J Transfus Sci 9:9–11. doi:10.4103/0973-6247.150938
Chigurupati P, Murthy KS (2015b) Automated nucleic acid amplification testing in blood banks: an additional layer of blood safety. Asian J Transfus Sci 9:9–11. doi:10.4103/0973-6247.150938
Davidson T, Ekermo B, Gaines H, Åkerlind BLA (2011) The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden. Transfusion 51:421–429. doi:10.1111/j.1537-2995.2010.02877.x
Dimeski G, Bird R, Brown N (2012) Measurement of glycated hemoglobin in a patient with homozygous hemoglobin E. Clin Chem Lab Med CCLM/FESCC 50:1479–1482. doi:10.1515/cclm-2011-0772
Garcia VD, Abbud-Filho M, Felipe C, Pestana JM (2015) An overview of the current status of organ donation and transplantation in Brazil. Transplantation 99:1535–1537. doi:10.1097/TP.0000000000000828
Gaum L, Reynolds I, Jones MN, Clarkson AJ, Gillan HL, Kaye SB (2012) Tissue and corneal donation and transplantation in the UK. Br J Anaesth 108(Suppl 1):i43–i47. doi:10.1093/bja/aer398
GENSCREEN® HIV1/2 version 2 (2006) Bio-Rad®
GENSCREEN™ ULTRA HIV Ag-Ab (2007) Bio-Rad®
Gubbe K et al (2012) Validation of Virus NAT for HIV, HCV, HBV and HAV using post-mortal blood samples. Transfus Med Hemother Offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 39:381–385. doi:10.1159/000345319
Gupta E, Bajpai M, Choudhary A (2014) Hepatitis C virus: screening, diagnosis, and interpretation of laboratory assays. Asian J Transfus Sci 8:19–25. doi:10.4103/0973-6247.126683
Hepanostika® HBsAg Ultra (2012) BioMérieux®
HIV combi PT: HIV-1 antigen and total antibodies to HIV-1 and HIV-2 (2015) Roche Diagnostics®
Hologic® (2012) Procleix® Ultrio® Assay
Howard RJ, Schold JD, Cornell DL (2005) A 10-year analysis of organ donation after cardiac death in the United States. Transplantation 80:564–568
Imuno-ELISA HCV (2012) Wama Diagnóstica®
Imuno-ELISA Anti-HBsAg (2012) Wama Diagnóstica®
Imuno-ELISA HIV 1 + 2 (2012) Wama Diagnóstica®
Imuno-ELISA HIV 1 + 2 (Ag/Ac) (2012) Wama Diagnóstica®
Interkit Anti-HBc: Anti HBc IgG, Anti Core do HBV-Enzimaimunoensaio (2014) Acon Biotech®
Interkit Anti-HCV: Hepatite C-Enzimaimunoensaio (2014) Acon Biotech®
Interkit HBsAg: Hepatite B-Enzimaimunoensaio (2014) Acon Biotech®
Interkit HIV: 4ª Geração Enzimaimunoensaio (2014) Acon Biotech®
Ison MG et al (2011) Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg 11:1218–1225. doi:10.1111/j.1600-6143.2011.03597.x
Kalus U, Wilkemeyer I, Caspari G, Schroeter J, Pruss A (2011) Validation of the serological testing for Anti-HIV-1/2, Anti-HCV, HBsAg, and Anti-HBc from post-mortem blood on the siemens-BEP-III automatic system. Transfus Med Hemother Offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 38:365–372. doi:10.1159/000334481
Kumar R, Gupta S, Kaur A, Gupta M (2015) Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety. Asian J Transfus Sci 9:199–202. doi:10.4103/0973-6247.154250
Lai JC, Kahn JG, Tavakol M, Peters MG, Roberts JP (2013) Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg 13:2611–2618. doi:10.1111/ajt.12429
Len O, Ramos A, Pahissa A (2012) Evaluating the risk of transmission of infection from donor to recipient of a solid organ transplantation. Enferm Infecc Microbiol Clin 30(Suppl 2):19–26. doi:10.1016/S0213-005X(12)70078-2
LIAISON® XL HIV Ag/Ab (2012) DiaSorin®
LIAISON® XL Murex® HCV Ab (2014) DiaSorin®
LIAISON® Anti-HBc (2014) DiaSorin®
LIAISON® HBc IgM (2014) DiaSorin®
LIAISON® HBsAg (2014) DiaSorin®
LIAISON® XL Murex® HBsAg Quant (2014) DiaSorin®
Linke SJ et al (2013) Thirty years of cornea cultivation: long-term experience in a single eye bank. Acta Ophthalmol 91:571–578. doi:10.1111/j.1755-3768.2012.02471.x
Lippi G et al (2008) Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med CCLM/FESCC 46:764–772. doi:10.1515/CCLM.2008.170
Michelon VG, Michelon T, Garcia VD, Marcon AS (2009) Avaliação das atividades do Banco de Olhos da Santa Casa de Porto Alegre 2003–2007. J Brasil Transpl 12:5
MONOLISA® anti-HBc PLUS (2006) Bio-Rad Laboratories®
MONOLISA® HBsAg: ULTRA (2007) Bio-Rad Laboratories®
Morgner F, Lecointre A, Charbonniere LJ, Lohmannsroben HG (2015) Detecting free hemoglobin in blood plasma and serum with luminescent terbium complexes. Phys Chem Chem Phys 17:1740–1745. doi:10.1039/c4cp04206a
Murex® HIV Ag/Ab Combination (2014) DiaSorin®
Murex® anti-HBc (total) (2014) DiaSorin®
Murex® anti-HCV (version 4.0) (2014) DiaSorin®
Murex® HBsAg Version 3 (2014) DiaSorin®
Organ procurement and transplantation network. Final rule (2013) vol 78, 2013/07/10 edn
PRISM® Hepatitis B Virus Core Antigen (2002) Abbott Laboratories®
PRISM® HBsAg: Antibody to Hepatitis B Surface Antigen (2005) Abbott Laboratories®
PRISM® HCV: Hepatitis C Virus Encoded Antigens (2008) Abbott Laboratories®
PRISM® HIV Ag/Ab Combo: human immunodeficiency Virus Type 1 and 2 (2008) Abbott Laboratories®
Pruss A, Caspari G, Kruger DH, Blumel J, Nubling CM, Gurtler L, Gerlich WH (2010) Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transpl Infect Dis Off J Transpl Soc 12:375–386. doi:10.1111/j.1399-3062.2010.00505.x
Roche® (2015a) Cobas® TaqScreen MPX. Roche Diagnostics®
Roche® (2015b) Cobas® TaqScreen MPX®
Saibaba KS, Bhaskar MV, Rao PV, Ramana GV, Dakshinamurty KV (1998) Interferences in clinical chemistry analysis. Indian J Clin Biochem IJCB 13:55–62. doi:10.1007/BF02867865
Sampaio TL, Rodrigues IP, Pontes DF, Ribeiro TK, Yamagushi CK, de Araujo WN, Bao SN (2015) Suitability of corneal tissue for transplantation derived from violent death: a 10-year analysis. Transpl Proc 47:2973–2977. doi:10.1016/j.transproceed.2015.07.034
Santos CGd, Pacini KM, Adán CBD, Sato EH (2010) Motivos do descarte de córneas captadas pelo banco de olhos do Hospital São Paulo em dois anos. Revista Brasileira de Oftalmologia 69:4
Shin DH et al (2014) Development of an integrated reporting system for verifying hemolysis, icterus, and lipemia in clinical chemistry results. Ann Lab Med 34:307–312. doi:10.3343/alm.2014.34.4.307
Shiratori CN, Hirai FE, Sato EH (2011) Características dos doadores de córneas do Banco de Olhos de Cascavel: impacto do exame anti-HBc para hepatite B. Arquivos Brasileiros de Oftalmologia 74:3
Siemens® (2013) ADVIA Centaur® e ADVIA Centaur® XP HCV (aHCV)
Sommese L et al (2014) Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems. Scand J Infect Dis 46:660–664. doi:10.3109/00365548.2014.926564
Sonntag O (1986) Haemolysis as an interference factor in clinical chemistry. J Clin Chem Clin Biochem Zeitschrift fur klinische Chemie und klinische Biochemie 24:127–139
Theodoropoulos N, Jaramillo A, Ladner DP, Ison MG (2013) Deceased organ donor screening for HIV, hepatitis B, and hepatitis C viruses: a survey of organ procurement organization practices. Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg 13:2186–2190. doi:10.1111/ajt.12260
Vironostika® HIV Ag/Ab (2010) BioMérieux®
Wang J, Wang MR (2013) [Comparative analysis of electro-chemiluminescence immunoassay and chemiluminescent microparticle immunoassay abilities to quantitatively assess hepatitis B surface antigen]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese J Hepatol 21:192–195
Acknowledgments
This work was supported by National Agency for Health Surveillance (ANVISA)/National Counsel for Scientific and Technological Development (CNPq) (Grants 403360/2012-9 and 440029/2014-7) and Foundation for Research Support of Distrito Federal (Grant 23098.021477.2015-87). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Language help was supported by Prime Scientífica LTDA-ME.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors of this manuscript have no conflicts of interest to disclose.
Rights and permissions
About this article
Cite this article
Victer, T.N.d., dos Santos, C.S.R., Báo, S.N. et al. Deceased tissue donor serology and molecular testing for HIV, hepatitis B and hepatitis C viruses: a lack of cadaveric validated tests. Cell Tissue Bank 17, 543–553 (2016). https://doi.org/10.1007/s10561-016-9564-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-016-9564-7